Tigecycline 50mg InjectionInjection
Antibiotics

Tigecycline 50mg Injection

Tigecycline

First-in-class glycylcycline antibiotic with broad-spectrum activity against MRSA, VRE, ESBL-producers, and anaerobes, approved for complicated skin/soft tissue and intra-abdominal infections. Manufactured by Cipla and Glenmark for hospital formulary export to critical care markets worldwide.

Strengths

50mg

Packing

1 vial/box

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Request QuotationWhatsApp
Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Tigecycline 50mg lyophilized powder for infusion
Dosage Form
Injection
Available Strengths
50mg
Packing
1 vial/box
Route of Administration
Intravenous infusion over 30-60 minutes
Dosage
Loading dose: 100mg IV, then 50mg IV every 12 hours for 5-14 days
Indications
Complicated skin and soft tissue infections, complicated intra-abdominal infections, community-acquired pneumonia
Country of Origin
India (WHO-GMP Certified)
Storage
Store below 25°C, reconstituted solution stable for 24 hours at room temperature
Shelf Life
24 months
Side Effects
Nausea, vomiting, diarrhea, abdominal pain, headache, increased liver enzymes, thrombocytopenia
Precautions
FDA black box: increased mortality risk vs comparators; not for diabetic foot infections; reserve for situations with no alternatives; monitor liver function; dose reduction in severe hepatic impairment

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Azithromycin 500mgTablet

Azithromycin 500mg

Azithromycin

Azalide subclass macrolide antibiotic that achieves exceptionally high and sustained intracellular tissue concentrations — up to 100-fold higher than plasma levels — enabling short 3-day or 5-day treatment courses for respiratory, skin, and sexually transmitted bacterial infections. Its anti-inflammatory properties beyond direct bacteriostasis provide additional clinical benefit in community-acquired pneumonia. Cipla and Alkem Labs manufacture 250mg and 500mg tablets exported globally as a staple of primary care antibiotic formularies.

250mg / 500mg
Amoxicillin 500mgCapsule

Amoxicillin 500mg

Amoxicillin Trihydrate

Aminopenicillin with extended gram-positive and gram-negative bactericidal activity, offering superior oral bioavailability (~90%) compared to ampicillin and the convenience of twice- or thrice-daily dosing for common community infections of the respiratory tract, urinary tract, skin, and ear. It is also a key component of H. pylori triple-eradication therapy and is a WHO Essential Medicine available in both capsule and dispersible tablet forms. Cipla and GSK manufacture 250mg and 500mg capsules exported to primary care markets globally.

250mg / 500mg
Augmentin 625mgTablet

Augmentin 625mg

Amoxicillin + Clavulanate

Fixed-dose combination of amoxicillin with clavulanic acid, a potent beta-lactamase inhibitor that protects amoxicillin from enzymatic degradation and restores its activity against beta-lactamase-producing strains of Staphylococcus, Haemophilus, Moraxella, and Klebsiella commonly encountered in community and hospital settings. Widely prescribed for sinusitis, otitis media, lower respiratory infections, UTIs, animal bites, and dental abscesses resistant to amoxicillin alone. GSK and Cipla supply 625mg and 1g tablets exported as a primary care antibiotic staple worldwide.

625mg / 1g

Need bulk pricing for Tigecycline 50mg Injection?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote